Fangcheng Zhang

723 total citations
17 papers, 533 citations indexed

About

Fangcheng Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fangcheng Zhang has authored 17 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Fangcheng Zhang's work include Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer Mechanisms and Therapy (2 papers). Fangcheng Zhang is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer Mechanisms and Therapy (2 papers). Fangcheng Zhang collaborates with scholars based in China, United States and Germany. Fangcheng Zhang's co-authors include Ningning Liu, Mingke Liu, Qiong Xu, Xuke Chen, Renjie Chai, Bin Liu, Ming Hu, Wenyi Zhou, Shiming Liu and Xiaohong Xia and has published in prestigious journals such as PLoS ONE, Advanced Science and European Journal of Pharmacology.

In The Last Decade

Fangcheng Zhang

15 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangcheng Zhang China 11 338 122 83 61 60 17 533
Xinping Luo China 15 449 1.3× 155 1.3× 94 1.1× 62 1.0× 56 0.9× 26 834
Michal Entin‐Meer Israel 17 449 1.3× 82 0.7× 123 1.5× 79 1.3× 86 1.4× 41 789
Chandran S. Abhinand India 9 292 0.9× 86 0.7× 53 0.6× 58 1.0× 44 0.7× 30 512
Shoji Kawauchi Japan 15 389 1.2× 178 1.5× 99 1.2× 85 1.4× 90 1.5× 37 784
Hye Suk Kang South Korea 15 420 1.2× 134 1.1× 54 0.7× 43 0.7× 104 1.7× 18 660
Sheng-Qian Wu United States 9 228 0.7× 94 0.8× 83 1.0× 23 0.4× 38 0.6× 9 551
Sasikumar J. Soumya India 5 246 0.7× 83 0.7× 49 0.6× 54 0.9× 40 0.7× 8 440
Xuezhi Yang China 14 308 0.9× 90 0.7× 201 2.4× 113 1.9× 45 0.8× 28 690
Chunlin Yang China 15 444 1.3× 105 0.9× 179 2.2× 97 1.6× 28 0.5× 43 783

Countries citing papers authored by Fangcheng Zhang

Since Specialization
Citations

This map shows the geographic impact of Fangcheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangcheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangcheng Zhang more than expected).

Fields of papers citing papers by Fangcheng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangcheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangcheng Zhang. The network helps show where Fangcheng Zhang may publish in the future.

Co-authorship network of co-authors of Fangcheng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fangcheng Zhang. A scholar is included among the top collaborators of Fangcheng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangcheng Zhang. Fangcheng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hu, Jijia, Zijing Zhu, Yiqun Hao, et al.. (2024). RBBP6‐Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney Disease. Advanced Science. 11(46). e2405153–e2405153. 3 indexed citations
2.
Chen, Junyu, Fei Hu, Yong Qiu, et al.. (2022). Primary Brainstem Lymphoma: A Population-Based Study. Frontiers in Surgery. 9. 829048–829048. 1 indexed citations
3.
Zhang, Zhenhui, Ningning Liu, Xiaohua Chen, et al.. (2021). UCHL1 regulates inflammation via MAPK and NF‐κB pathways in LPS‐activated macrophages. Cell Biology International. 45(10). 2107–2117. 16 indexed citations
4.
Chen, Junyu, et al.. (2021). Clinical characteristics and outcomes of primary intracranial alveolar soft-part sarcoma: A case report. World Journal of Clinical Cases. 10(1). 296–303.
5.
Ling, Sisi, Shizheng Li, Fangcheng Zhang, et al.. (2021). Allium macrostemon Saponin Inhibits Activation of Platelet via the CD40 Signaling Pathway. Frontiers in Pharmacology. 11. 12 indexed citations
6.
Yuan, Ye, Nanxiang Xiong, Qiangping Wang, et al.. (2021). Reconstruction of Craniectomy for Microvascular Decompression with Autologous Particulate Bone. Journal of Neurological Surgery Part A Central European Neurosurgery. 82(6). 538–543. 4 indexed citations
7.
Zhang, Fangcheng, Renjie Chai, Qiong Xu, et al.. (2020). Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B. Frontiers in Molecular Biosciences. 7. 49–49. 13 indexed citations
8.
Zhang, Fangcheng, Xiaohong Xia, Renjie Chai, et al.. (2020). Inhibition of USP14 suppresses the formation of foam cell by promoting CD36 degradation. Journal of Cellular and Molecular Medicine. 24(6). 3292–3302. 42 indexed citations
9.
Xu, Qiong, Mingke Liu, Fangcheng Zhang, et al.. (2020). Ubiquitin‐specific protease 2 regulates Ang Ⅱ–induced cardiac fibroblasts activation by up‐regulating cyclin D1 and stabilizing β‐catenin in vitro. Journal of Cellular and Molecular Medicine. 25(2). 1001–1011. 12 indexed citations
10.
Liu, Ningning, Zhiqiang Guo, Xiaohong Xia, et al.. (2019). Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling. European Journal of Pharmacology. 846. 1–11. 35 indexed citations
11.
Xia, Xiaohong, Yuan Liu, Yuning Liao, et al.. (2019). Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC. European Journal of Pharmacology. 856. 172409–172409. 17 indexed citations
12.
Zhang, Fangcheng, Renjie Chai, Wenyi Zhou, et al.. (2019). Exosomes derived from pro‐inflammatory bone marrow‐derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization. Journal of Cellular and Molecular Medicine. 23(11). 7617–7631. 203 indexed citations
13.
Hu, Ming, Zhenhui Zhang, Bin Liu, et al.. (2018). Deubiquitinase Inhibitor Auranofin Attenuated Cardiac Hypertrophy by Blocking NF-κB Activation. Cellular Physiology and Biochemistry. 45(6). 2421–2430. 19 indexed citations
14.
Xia, Xiaohong, Yuning Liao, Zhiqiang Guo, et al.. (2018). Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer. Oncogenesis. 7(9). 75–75. 53 indexed citations
15.
16.
Lei, Deqiang, Xingli Deng, Hongyang Zhao, Fangcheng Zhang, & Ruen Liu. (2017). Inhibition of tumor growth and angiogenesis by 2-(4-aminophenyl) benzothiazole in orthotopicglioma C6 rat model. Saudi Journal of Biological Sciences. 25(7). 1483–1487. 4 indexed citations
17.
Zhang, Fangcheng. (2006). Surgical Dissection of Dorsal Root Ganglions and Sympathetic Ganglions in Living Rats.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinping Luo Breakdown of academic impact, for papers by Michal Entin‐Meer Breakdown of academic impact, for papers by Chandran S. Abhinand Breakdown of academic impact, for papers by Shoji Kawauchi Breakdown of academic impact, for papers by Hye Suk Kang Breakdown of academic impact, for papers by Sheng-Qian Wu Breakdown of academic impact, for papers by Sasikumar J. Soumya Breakdown of academic impact, for papers by Xuezhi Yang Breakdown of academic impact, for papers by Chunlin Yang
Rankless by CCL
2026